Greg Rosenfeld

Dr. Greg Rosenfeld

St. Paul’s Hospital

About

Greg Rosenfeld MD, MHSc, FRCPC, CCFP

Clinical Assistant Professor of Medicine,

Division of Gastroenterology,

University of British Columbia

770 - 1190 Hornby Street

Vancouver, BC V6Z 2K5

Phone: 604-688-6332

Fax: 604-689-2004

Profile

Dr. Greg Rosenfeld completed his undergraduate training in Science and Medicine at UBC in 1992. He worked as a family physician and Clinical Assistant Professor in the department of Family Practice at UBC until completing an Internal Medicine Residency, Gastroenterology and Advanced Fellowships in IBD at UBC. He holds an MHSc. In Clinical Epidemiology from UBC. Dr. Rosenfeld practices with the St. Paul’s Hospital Gastroenterology group and has a clinical practice focus in IBD. He is an associate physician of the BC Home Enteral and Parenteral Nutrition Program.

Research Interests

Dr Rosenfeld’s research interests are in diagnostic techniques for IBD and clinical Epidemiology. He participates in a two national groups utilizing population databases for studying the incidence and prevalence of IBD in Canada. As well he has performed several studies involving novel imaging techniques for managing IBD patients and further studies utilizing new biomarkers such as fecal calprotectin to investigate and monitor disease activity.

Teaching

Dr. Rosenfeld has been involved in teaching Medical undergraduate students, Medical Residents, Gastroenterology Fellows and Advanced Fellows in IBD. He also lectures for Continuing Medical Education of practicing physicians. He has also lectured to the public through interest groups such as Crohn’s and Colitis Canada

Memberships

Royal College of Physicians and Surgeons of Canada Member

 

 2011 – present
Canadian Association of Gastroenterology, Crohn’s Guidelines Panel Member

 

 2010 – present
American College of Gastroenterology Member

 

 2011 – present
American Gastroenterology Association Member 2011 – present
Canadian Medical Association Member 1993 – present
British Columbia Medical Association Member 1992 – present

Publications

Peer-Reviewed Articles in Scholarly Journals

  1. Mitchell RA, Shuster C, Shahidi N, Galorport C, DeMarco ML, Rosenfeld G, Enns RA, Bressler B. “The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience,” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, Article ID 5203898, 7 pages, 2016. Doi:10.1155/2016/5203898.
  2. Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World J Gastroenterol. 2016; 22(36): 8211-8218.
  3. Rosenfeld G, Parker CE, MacDonald JK, Bressler B. Etrolizumab for Induction of Remission in Ulcerative Colitis. Cochrane Database Syst Rev. 2015 Dec 2;(12).
  4. Ou G, Rosenfeld G, Brown J, Hong, T, Chan N and Bressler B. Colonoscopy After CT Diagnosed Acute Diverticulitis: Is It Really Necessary? Canadian Journal of Surgery. 2015 Aug;58(4):226-31.
  5. Charlebois A, Rosenfeld G, Bressler B. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review. Critical Reviews in Food Science and Nutrition. January 2015; 8:0.
  6. Rush B, Berger L, Rosenfeld G, Bressler B. Tacrolimus Therapy for Ulcerative Colitis-Associated Post-Colectomy Enteritis. ACG Case Reports Journal. 2014;2(1):33–35.
  7. Kolypov U, Rosenfeld G, Bressler B, Seidman E, Clinical Utility of Fecal Biomarkers for Diagnosis and Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases April 2014;20:742 – 756
  8. Rosenfeld G, Fu N, Quiney B, Qian H, Krygier D, Brown J, Vos P, Tiwari P, Telford J, Bressler B, Enns R, DETECT: Determing The Effect of Training and Experience on the Accuracy of CT (Computed Tomography)          Colonography in Comparison with Optical Colonoscopy in the Detection of Colonic Neoplasia. World Journal of Gastroenterology. Feb 14, 2014; 20(6): 1574–1581.
  9. Rosenfeld G, Qian H, Bressler B. The Risks of Post-Operative Complications Following Pre-Operative Infliximab Therapy For Crohn’s Disease in Patients Undergoing Abdominal Surgery: A Systematic Review and Meta-Analysis. Journal of Crohn’s and Colitis Dec. 2013;7(11): 868-877
  10. Bach H, Rosenfeld G, Bressler B. Treatment of Crohn's disease patients with infliximab is detrimental for the survival of Mycobacterium avium ssp. paratuberculosis within macrophages and shows a remarkable decrease in the immunogenicity of mycobacterial proteins. Journal of Crohn’s and Colitis June 2012; 6(5): 628-629.
  11. Brahmania M, Schwartz Z, Rosenfeld G, Yoshida  E. Sertraline Induced Hepatotoxicity: A Case Report and Review of Literature. The Internet Journal of Gastroenterology. 2011 Volume 10 Number 2
  12. Rosenfeld G, Chang A, Poulin M, Kwan P, Yoshida E. Cholestatic jaundice, acute renal failure and acute pancreatitis secondary to methandrostenolone: a case report of recreational anabolic steroid use. The Journal of Medical Case Reports. April 6, 2011;5:138.

Non-Refereed Contributions

Journal Articles

  1. Rosenfeld G, Freeman H, Brown M, Steinbrecher U. Severe Enteritis Following Colectomy for Ulcerative Colitis. Canadian Journal of Gastroenterology Dec. 2012; 26(12):866-867
  2. Rosenfeld G, Nimmo M, Hague C, Buczkowski A, Yoshida EM. Echinococcus Presenting as Painless Jaundice. Canadian Journal of Gastroenterology Oct. 2012; 26(10):684-685
  3. Rosenfeld G, Bressler B. The truth about cigarette smoking and the risk of Inflammatory Bowel Disease. American Journal of Gastroenterology. Sept. 2012; 107:1407-1408.
  4. Rosenfeld G, Bressler B, Letter to the Editor. The Canadian Journal of Gastroenterology. June 2011;25:300.

Online Publications

  1. Rosenfeld G, This Changed My Practice. Fecal Biomarkers in the Diagnosis and Management of Inflammatory Bowel Disease. Dec. 10, 2014. http://www.mailoutinteractive.com/Industry/View.aspx?id=642529&q=815674457&qz=c1d1ea